Nigella sativa pharmacological applications
Nigella sativa pharmacological applications is a research topic within Complementary and alternative medicine. Science Explorer counts 5.7k research works in it since 1951. 10.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the therapeutic potential of Nigella sativa, focusing on its antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. The research covers the pharmacological and toxicological properties of Nigella sativa, as well as the effects of its active component, thymoquinone, on various health conditions such as cancer, diabetes, and neurodegenerative diseases.
- Nigella sativa
- Thymoquinone
- Antioxidant
- Anti-inflammatory
- Cancer
- Immunomodulatory
- Pharmacological properties
- Toxicological properties
- Hepatoprotective effects
- Anticancer activity
- Research works
- 5.7k fractional, since 1951
- In the world top 10%
- 581 per year above
- Top-10% rate
- 10.3% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +12% the tick is no change
- Largest producer
India
22% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Nigella sativa pharmacological applications research?
By volume, India and Indonesia publish the most (314 and 184 works in 2022-now).
Türkiye
China
Nigeria
PakistanHow concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Nigella sativa pharmacological applications research?
By volume in 2022-now, Islamic Azad University, Tehran publishes the most Nigella sativa pharmacological applications research, followed by King Saud University and Cairo University.
By volume, 2022-now
- 1
Islamic Azad University, Tehran
Iran
24 works
- 2
King Saud University
Saudi Arabia
15 works
- 3
Cairo University
Egypt
15 works
- 4
Airlangga University
Indonesia
13 works
- 5
Ain Shams UniversityEgypt
13 works
- 6
King Abdulaziz UniversitySaudi Arabia
11 works
- 7
Saveetha UniversityIndia
11 works
- 8
Zagazig UniversityEgypt
11 works
- 9
Indian Council of Agricultural ResearchIndia
11 works
- 10
University of Baghdad
Iraq
10 works
Who are the leading researchers in Nigella sativa pharmacological applications?
The most-cited researchers publishing on Nigella sativa pharmacological applications include Amirhossein Sahebkar and Bharat Bhushan Aggarwal.
- 1
Amirhossein Sahebkar
Iran
258k citations
- 2
Bharat Bhushan Aggarwal
United States
142k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Nigella sativa pharmacological applications research done?
The largest centres of Nigella sativa pharmacological applications research in 2022-now are Tehran (Iran), Cairo (Egypt), Giza (Egypt) and Riyadh (Saudi Arabia). Among places with at least 20 works in it, it is an unusually large share of all research in Giza.
Largest cities, 2022-now
Where it is the local speciality
- GizaEG · 33.1 works13×
Location quotient: how much more of its research is in Nigella sativa pharmacological applications than the world average.
Where is the best place to study Nigella sativa pharmacological applications?
Among universities, judged by research, King Saud University, Cairo University and Mansoura University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | King Saud UniversitySaudi Arabia |
81.8 | 26.2% | 9.8× | 16 | +3.6% |
| 2 | Cairo UniversityEgypt |
58.9 | 9.5% | 12.4× | 15 | +55.8% |
| 3 | Mansoura UniversityEgypt |
53.4 | 19.8% | 12.8× | 9 | +56.8% |
| 4 | Islamic Azad University, TehranIran |
53.0 | 4.7% | 9.0× | 24 | +4.7% |
| 5 | Ain Shams UniversityEgypt |
48.3 | 9.3% | 10.9× | 12 | +29.8% |
| 6 | Tabriz University of Medical SciencesIran |
48.1 | 11.5% | 21.6× | 9 | +7.0% |
| 7 | Mashhad University of Medical SciencesIran |
42.8 | 17.6% | 25.2× | 9 | -56.9% |
| 8 | King Abdulaziz UniversitySaudi Arabia |
41.1 | 4.4% | 13.2× | 12 | -20.4% |
| 9 | Zagazig UniversityEgypt |
40.8 | 12.6% | 18.0× | 11 | -12.4% |
| 10 | Al-Azhar UniversityEgypt |
40.4 | 13.4% | 16.2× | 10 | -23.3% |
| 11 | Saveetha UniversityIndia |
35.8 | 10.6% | 7.1× | 11 | +86.2% |
| 12 | Assiut UniversityEgypt |
33.8 | 6.6% | 20.1× | 9 | +9.9% |
| 13 | Airlangga UniversityIndonesia |
30.8 | 0.6% | 9.2× | 13 | +63.1% |
| 14 | Benha UniversityEgypt |
26.3 | 4.3% | 18.7× | 9 | +0.8% |
| 15 | University of BaghdadIraq |
22.9 | 0.2% | 9.1× | 10 | +29.5% |
| 16 | University of BrawijayaIndonesia |
3.1 | 0.0% | 6.9× | 10 | -16.7% |
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Nigella sativa pharmacological applications, country by countryIs Nigella sativa pharmacological applications research growing?
Output in 2022-2025 was 12% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Nigella sativa pharmacological applications.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Nigella sativa pharmacological applications as a percentage of every work published that year, 0.0082% in 2024.
Fractional works of Nigella sativa pharmacological applications over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Nigella sativa pharmacological applications. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.